(Q24248628)

2

0 references

GJ Hofmeyr

3

0 references

LN Cheng

4

0 references

A Campana

Cochrane Database of Systematic Reviews

5

0 references

publication date

19 August 2003

0 references

published in

0 references

cites work

Interruption of early pregnancy with mifepristone in combination with gemeprost

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Commercial availability of misoprostol and induced abortion in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Endocrinology: Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Conditions for choosing between drug-induced and surgical abortions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Methotrexate and misoprostol for early abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05--a multicentre randomized clinical trial in China

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

The use of misoprostol for termination of early pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Oral methotrexate and vaginal misoprostol for early abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Timing of pain and bleeding after mifepristone-induced abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study--final results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

The use of misoprostol for termination of early pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Misoprostol 3, 4, or 5 days after methotrexate for early abortion. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Oral methotrexate and vaginal misoprostol for early abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Misoprostol used alone for the termination of early pregnancy. A review of the evidence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Tamoxifen compared to methotrexate when used with misoprostol for abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Methotrexate and misoprostol used alone or in combination for early abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Medical abortion in early pregnancy: a review of the evidence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Termination of early pregnancy with ZK 98,734: pharmacokinetic behaviour and clinical effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

Options for early therapeutic abortion: a comparative review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

No abortion-inducing effect of the ulcer-healing dose of the synthetic prostaglandin E2 analogue enprostil in first trimester

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002855.PUB2

7 January 2021

10.1002/14651858.CD002855.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3825414

OpenCitations bibliographic resource ID

3825414

1 reference